Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KCNJ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SRGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505978 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MAGEC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM53A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MIR3681HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLSPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAZ2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTNG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMXL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEIS3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DICER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on